Researchers at Baylor College of Medicine have discovered a potentially transformative approach to Alzheimer's and Parkinson's disease. Rather than stopping toxic proteins like Tau and alpha-synuclein from clumping inside brain cells, they found that tubulin—the protein that forms a cell's internal transport system—can redirect these proteins toward healthy, productive functions instead. This represents a fundamental shift in treatment strategy: redirecting the problem rather than simply blocking it, according to ScienceDaily.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton